Immediate Impact
1 by Nobel laureates 3 from Science/Nature 51 standout
Citing Papers
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
CRISPR technologies for genome, epigenome and transcriptome editing
2024 Standout
Works of Andreas Varkaris being referenced
WNT5a Signaling through ROR2 Activates the Hippo Pathway to Suppress YAP1 Activity and Tumor Growth
2023
EGFR-A763_Y764insFQEA Is a Unique Exon 20 Insertion Mutation That Displays Sensitivity to Approved and In-Development Lung Cancer EGFR Tyrosine Kinase Inhibitors
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Andreas Varkaris | 316 | 324 | 381 | 45 | 802 | |
| Hideaki Mitsui | 284 | 316 | 387 | 47 | 846 | |
| Daniel Brattström | 392 | 445 | 359 | 42 | 859 | |
| Guoshuang Shen | 344 | 504 | 292 | 57 | 945 | |
| Fei Xu | 388 | 460 | 292 | 59 | 872 | |
| François Ringeisen | 301 | 368 | 512 | 32 | 886 | |
| Haruyoshi Tanaka | 305 | 343 | 490 | 50 | 925 | |
| Lars Tharun | 231 | 421 | 449 | 39 | 921 | |
| Kai Zhu | 284 | 240 | 554 | 48 | 988 | |
| Xueguan Lu | 159 | 209 | 333 | 56 | 724 | |
| Chao‐Nan Qian | 266 | 300 | 205 | 33 | 784 |
All Works
Login with ORCID to disown or claim papers
Loading papers...